Psychedelic Business Spotlight: October 22
Business, Stock Reports
This week in psychedelic business news: UK fast tracks DMT for major depressive disorder; Field Trip Health expands its clinical presence in the US; and another psychedelic pharmaceuticals company prepares for the Nasdaq.
This is really cool
Was brain activity measured during these trips of DMT ? Was it disabled or just low activity?
Good news for Small Pharma and others.
Regarding the assertion that DMT has been in use “…for thousands of years by indigenous groups (especially the Americas and Australia)…”
I thought that I had read that the Australian Aborigines were one of the few indigenous peoples that had no tradition whatsoever of psychedelic use….anyway, very interesting stuff.